142 related articles for article (PubMed ID: 31135623)
1. Reversible Conduction Failure in Chronic Immune-Mediated Sensorimotor and Autonomic Polyneuropathy.
Shouman K; Dhamne M; Li Y
J Clin Neuromuscul Dis; 2019 Jun; 20(4):200-206. PubMed ID: 31135623
[TBL] [Abstract][Full Text] [Related]
2. Post COVID-19 Guillain-Barre syndrome presents as sensory dominant neuropathy with reversible conduction failure.
AlTahan AM; AlAnazi MH; AlTahan FA; AlAbandi FA
Neurosciences (Riyadh); 2023 Jan; 28(1):57-61. PubMed ID: 36617454
[TBL] [Abstract][Full Text] [Related]
3. Chronic Inflammatory Demyelinating Polyneuropathy Manifesting as Neuropathy With Liability to Pressure Palsies: A Case Report.
Shah A; Rison RA; Beydoun SR
J Clin Neuromuscul Dis; 2015 Dec; 17(2):78-83. PubMed ID: 26583495
[TBL] [Abstract][Full Text] [Related]
4. Acute-onset chronic inflammatory demyelinating polyneuropathy with cranial nerve involvement, dysautonomia, respiratory failure, and autoantibodies.
Hantson P; Kevers L; Fabien N; Van Den Bergh P
Muscle Nerve; 2010 Mar; 41(3):423-6. PubMed ID: 19918775
[TBL] [Abstract][Full Text] [Related]
5. Electrodiagnosis of reversible conduction failure in Guillain-Barré syndrome.
Chan YC; Punzalan-Sotelo AM; Kannan TA; Shahrizaila N; Umapathi T; Goh EJH; Fukami Y; Wilder-Smith E; Yuki N
Muscle Nerve; 2017 Nov; 56(5):919-924. PubMed ID: 28093784
[TBL] [Abstract][Full Text] [Related]
6. [Good response to intravenous immunoglobulin therapy in sensory dominant distal variant of chronic inflammatory demyelinating polyneuropathy].
Takeshita Y; Koga M; Omoto M; Ogasawara J; Kawai M; Kanda T
Rinsho Shinkeigaku; 2011 Jul; 51(7):478-82. PubMed ID: 21823506
[TBL] [Abstract][Full Text] [Related]
7. Electrodiagnostic criteria for Guillain-Barrè syndrome: a critical revision and the need for an update.
Uncini A; Kuwabara S
Clin Neurophysiol; 2012 Aug; 123(8):1487-95. PubMed ID: 22480600
[TBL] [Abstract][Full Text] [Related]
8. Electrophysiological testing in chronic inflammatory demyelinating polyneuropathy patients treated with subcutaneous immunoglobulin: The Polyneuropathy And Treatment with Hizentra (PATH) study.
Bril V; Hartung HP; Lawo JP; Durn BL; Mielke O
Clin Neurophysiol; 2021 Jan; 132(1):226-231. PubMed ID: 33039291
[TBL] [Abstract][Full Text] [Related]
9. Focal sensory chronic inflammatory demyelinating polyneuropathy (CIDP).
Shouman K; Dubey D; Engelstad JK; Dyck PJB
Muscle Nerve; 2021 May; 63(5):E46-E49. PubMed ID: 33594681
[No Abstract] [Full Text] [Related]
10. Optimizing the electrodiagnostic accuracy in Guillain-Barré syndrome subtypes: Criteria sets and sparse linear discriminant analysis.
Uncini A; Ippoliti L; Shahrizaila N; Sekiguchi Y; Kuwabara S
Clin Neurophysiol; 2017 Jul; 128(7):1176-1183. PubMed ID: 28521265
[TBL] [Abstract][Full Text] [Related]
11. Pitfalls in electrodiagnosis of Guillain-Barré syndrome subtypes.
Uncini A; Manzoli C; Notturno F; Capasso M
J Neurol Neurosurg Psychiatry; 2010 Oct; 81(10):1157-63. PubMed ID: 20870864
[TBL] [Abstract][Full Text] [Related]
12. Distal acquired demyelinating symmetric polyneuropathy progressing to classic chronic inflammatory demyelinating polyneuropathy and response to fludarabine and cyclophosphamide.
Leitch MM; Sherman WH; Brannagan TH
Muscle Nerve; 2013 Feb; 47(2):292-6. PubMed ID: 23168526
[TBL] [Abstract][Full Text] [Related]
13. Atypical childhood chronic inflammatory demyelinating polyneuropathy.
Mohamed AR; Rodriguez-Casero MV; Ryan MM
Muscle Nerve; 2010 Aug; 42(2):293-5. PubMed ID: 20589891
[TBL] [Abstract][Full Text] [Related]
14. A case of POEMS mimicking a "Guillain-Barré like" syndrome.
Abbas A; Cook M; Hiew FL; Lewthwaite A; Shirley C; Rajabally YA
J Neurol Sci; 2016 Oct; 369():268-270. PubMed ID: 27653904
[No Abstract] [Full Text] [Related]
15. [A quadriplegic patient with chronic inflammatory demyelinating polyneuropathy (CIDP) who responded well to corticosteroids and intravenous immunoglobulin therapy].
Fukae J; Okuma Y; Noda K; Fujishima K; Goto K; Mizuno Y
No To Shinkei; 2001 Dec; 53(12):1115-8. PubMed ID: 11806118
[TBL] [Abstract][Full Text] [Related]
16. Electrophysiology in chronic inflammatory demyelinating polyneuropathy with IGIV.
Bril V; Katzberg H; Donofrio P; Banach M; Dalakas MC; Deng C; Hanna K; Hartung HP; Hughes RA; Latov N; Merkies IS; van Doorn PA;
Muscle Nerve; 2009 Apr; 39(4):448-55. PubMed ID: 19260050
[TBL] [Abstract][Full Text] [Related]
17. CIDP presenting as recurrent severe back pain without weakness or sensory loss.
Bäumer D; Grant DJ; Knight R; Buckley C; Bennett D; Rinaldi S
Pract Neurol; 2016 Dec; 16(6):488-492. PubMed ID: 27313227
[TBL] [Abstract][Full Text] [Related]
18. Two sets of nerve conduction studies may suffice in reaching a reliable electrodiagnosis in Guillain-Barré syndrome.
Shahrizaila N; Goh KJ; Abdullah S; Kuppusamy R; Yuki N
Clin Neurophysiol; 2013 Jul; 124(7):1456-9. PubMed ID: 23395599
[TBL] [Abstract][Full Text] [Related]
19. CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.
Névoret ML; Vinik AI
J Diabetes Complications; 2015 Mar; 29(2):313-7. PubMed ID: 25466645
[TBL] [Abstract][Full Text] [Related]
20. Clinicopathological features of neuropathy associated with lymphoma.
Tomita M; Koike H; Kawagashira Y; Iijima M; Adachi H; Taguchi J; Abe T; Sako K; Tsuji Y; Nakagawa M; Kanda F; Takeda F; Sugawara M; Toyoshima I; Asano N; Sobue G
Brain; 2013 Aug; 136(Pt 8):2563-78. PubMed ID: 23884813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
